LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.001
 23.10 84.90 94 1616 0.0582 0.0243
MN20160318_Q02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 23.10 84.90 1586 1616 0.9813 0.9911
MN20160318_Q02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 24.81 84.90 45 1769 0.0254 -0.1349
MN20160318_Q02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 24.81 84.90 1477 1769 0.8347 0.9192
MN20160318_Q02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 24.81 84.90 115 1769 0.0650 0.0717
MN20160318_Q02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 24.81 84.90 1673 1769 0.9455 0.9746
MN20160318_Q02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 26.51 84.90 46 1923 0.0239 -0.1273
MN20160318_Q02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 26.51 84.90 1478 1923 0.7685 0.8864
MN20160318_Q02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 26.51 84.90 138 1923 0.0718 0.1140
MN20160318_Q02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 26.51 84.90 1757 1923 0.9136 0.9603
MN20160318_Q02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 28.21 84.90 50 2091 0.0239 -0.1082
MN20160318_Q02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 28.21 84.90 1515 2091 0.7244 0.8652
MN20160318_Q02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 28.21 84.90 151 2091 0.0722 0.1327
MN20160318_Q02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 28.21 84.90 1839 2091 0.8793 0.9451
MN20160318_Q02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 29.92 84.90 67 2237 0.0299 -0.0489
MN20160318_Q02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 29.92 84.90 1738 2237 0.7767 0.8957
MN20160318_Q02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 29.92 84.90 168 2237 0.0751 0.1556
MN20160318_Q02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 29.92 84.90 1961 2237 0.8763 0.9448
MN20160318_Q02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 31.62 84.90 85 2449 0.0347 0.0003
MN20160318_Q02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 31.62 84.90 1858 2449 0.7585 0.8892
MN20160318_Q02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 31.62 84.90 174 2449 0.0710 0.1594
MN20160318_Q02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 31.62 84.90 2105 2449 0.8593 0.9384
MN20160318_Q02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 33.32 84.90 88 2722 0.0323 0.0072
MN20160318_Q02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 33.32 84.90 1975 2722 0.7255 0.8757
MN20160318_Q02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 33.32 84.90 196 2722 0.0720 0.1820
MN20160318_Q02
N21